SkinHealth Systems Inc. filed a Form 8-K with the SEC on November 5, 2026, announcing its financial results for the fiscal quarter ended September 30, 2026, alongside an accompanying press release and conference call.

Key Highlights

  • Filing date: November 5, 2026, covering the fiscal quarter ended September 30, 2026.
  • Exchange listing: Class A Common Stock, par value $0.0001 per share, trades on NASDAQ:SKIN.
  • Results announcement: The company issued a press release on November 5, 2026, regarding its quarterly financial results, furnished as Exhibit 99.1.
  • Non-GAAP disclosures: The company disclosed it referenced non-GAAP financial information in both the press release and the conference call, with a GAAP-to-non-GAAP reconciliation provided in Exhibit 99.1.
  • Signatory: The filing was signed by Michael Monahan, Chief Financial and Operating Officer.
  • Emerging growth company: The company indicated it is not an emerging growth company under the applicable SEC definitions.

SkinHealth Systems Discloses Quarterly Results Under Item 2.02

According to the filing, SkinHealth Systems Inc., a Delaware-incorporated company headquartered at 3600 E. Burnett Street, Long Beach, California, reported its financial results for the fiscal quarter ended September 30, 2026, through an Item 2.02 current report. The company's Class A Common Stock carries a par value of $0.0001 per share and is listed on the Nasdaq Capital Market under the ticker symbol SKIN.

The filing states that a press release, furnished as Exhibit 99.1, was issued on November 5, 2026, and that the company also held a conference call in connection with the quarterly results. As the filing disclosed, the information provided under Item 2.02 and in Exhibit 99.1 "shall not be deemed 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934, as amended." The company also noted that the press release contains a reconciliation of GAAP to non-GAAP financial measures.

The filing further noted that SkinHealth Systems discloses material information through multiple channels, including regulatory filings, press releases, and public conference calls, as part of its obligations under Regulation FD. The report was signed by Michael Monahan in his capacity as Chief Financial and Operating Officer, on behalf of the registrant, dated November 5, 2026.

What Was Disclosed

SkinHealth Systems Inc. filed an 8-K on November 5, 2026, under Item 2.02, furnishing a press release as Exhibit 99.1 that covered financial results for the fiscal quarter ended September 30, 2026, and referenced both GAAP and non-GAAP financial measures.